COVID-19 Statement

Last updated 4th August 2020

Dear Client/Patient

We would like to reassure you about the safety of our at-home cancer screening services and risk assessments in light of the COVID-19 outbreak.  All of our testing kits for bowel, cervical, lung and prostate cancer screening are sent to your home and therefore, do not require you to attend an outpatient setting or hospital.  MyBreastRisk is also a home testing kit to provide you with a personal breast cancer risk assessment.  We are in continued contact with our laboratory and all necessary measures are in place to ensure that we can continue to process and deliver results.  With NHS cancer services now beginning to gather momentum, those patients with an abnormal test result will have the option to have further investigations in the NHS or private sector, accepting that there may be a slight delay to access the NHS. If you would like to speak to us please call 0800 085 6663.

We would also like to reassure you about the safety of our breast, prostate and skin diagnostic pathways in light of the COVID-19 outbreak. We are working very closely with our Consultants and Specialist Nurses to ensure that all necessary Government advice is being followed. As a result of this, we continue to be able to provide rapid access into our national network of breast, skin and prostate pathways. If you have travelled overseas, have a fever of at least 37.8 degrees Celsius, have developed a new, dry persistent cough, or lost your sense of smell and taste please do not attend your appointment and contact our team who will be happy to reschedule for you. If you would like to speak to us please call 0800 085 6663.